Anticancer Activity of Buttermilk Against SW480 Colon Cancer Cells is Associated with Caspase-Independent Cell Death and Attenuation of Wnt, Akt, and ERK Signaling

Nutrition and Cancer

Volumn 68, Issue 7, 2016, Pages 1234-1246

  Kuchta Noctor, Anna M ^a   Murray, Brian A ^b   Stanton, Catherine ^b   Devery, Rosaleen ^a   Kelly, Phil M ^b  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CASPASE; DNA; LACTOSYLCERAMIDE; MILK FAT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PROTEIN KINASE B; SPHINGOLIPID; SPHINGOMYELIN; WNT PROTEIN; AKT1 PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; ATTENUATION; BUTTER; CANCER CELL; CANCER GROWTH; CELL CYCLE; CELL MEMBRANE DEPOLARIZATION; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREAM; CYTOTOXICITY; DNA DEGRADATION; DOWN REGULATION; DRUG SELECTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; LIPID COMPOSITION; MICROFILTRATION; MILK; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; ONCOGENE C MYC; WNT SIGNALING PATHWAY; ANALYSIS; ANTAGONISTS AND INHIBITORS; BUTTERMILK; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; COLON TUMOR; COMPARATIVE STUDY; DAIRYING; FOOD HANDLING; FUNCTIONAL FOOD; MAPK SIGNALING; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PILOT STUDY; PROTEIN PROCESSING; TUMOR CELL LINE; WNT SIGNALING;

BUTTERMILK; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; DAIRYING; DOWN-REGULATION; FOOD HANDLING; FUNCTIONAL FOOD; HUMANS; MAP KINASE SIGNALING SYSTEM; MEMBRANE POTENTIAL, MITOCHONDRIAL; PHOSPHOLIPIDS; PHOSPHORYLATION; PILOT PROJECTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; SPHINGOLIPIDS; WNT SIGNALING PATHWAY;

EID: 84980041639     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2016.1206580     Document Type: Article

References (26)

1. R.N.Grant:Yogurt and buttermilk in cancer management. JAMA 210, 1769–1770, 1969.
2. R.C.Sprong, M.F.E.Hulstein, T.T.Lambers, and R.Van der Mee:Sweet buttermilk intake reduces colonisation and translocation of Listeria monocytogenes in rats by inhibiting mucosal pathogen adherence. BJN 108, 2026–2033, 2012.
3. V.Conway, P.Couture, C.Richard, S.Gauthier, Y.Pouliot, et al.:Impact of buttermilk consumption on plasma lipids and surrogate markers of cholesterol homeostasis in men and women. NMCD 23, 1255–1262, 2013.
4. V.Conway, P.Couture, S.Gauthier, Y.Pouliot, and B.Lamarche:Effect of buttermilk consumption on blood pressure in moderately hypercholesterolemic men and women. Nutrition 30, 116–119, 2014.
5. D.R.Snow, R.Jimenez-Flores, R.E.Ward, J.Cambell, M.J.Young, et al.:Dietary milk fat globule membrane reduces the incidence of aberrant crypt foci in fischer-344 rats. J Agric Food Chem 58, 2157–2163, 2010.
6. K.Dewettinck, R.Rombaut, N.Thienpont, T.T.Le, K.Messens, et al.:Nutritional and technological aspects of milk fat globule membrane material. Int Dairy J 18, 436–457, 2008.
7. V.L.Spitsberg:Bovine milk fat globule membrane as a potential nutraceutical. J Dairy Sci 88, 2289–2294, 2005.
8. A.M.Kuchta, P.M.Kelly, C.Stanton, and R.A.Devery:Milk fat globule membrane-a source of polar lipids for colon health? Int J Dairy Technol 65, 315–333, 2012.
9. D.L.Dillehay, S.K.Webb, E.M.Schmelz, and A.H.Merrill:Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J Nutr 124, 615–620, 1994.
10. E.M.Schmelz, M.C.Sullards, D.L.Dillehay, and A.H.Merrill:Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1,2-dimethylhydrazine-treated CF1 mice. J Nutr 130, 522–527, 2000.
11. L.A.Lemonnier, D.L.Dillehay, M.J.Vespremi, J.Abrams, E.Brody, et al.:Sphingomyelin in the suppression of colon tumors:prevention versus intervention. Arch Biochem Biophys 419, 129–138, 2003.
12. R.Zanabria, A.M.Tellez, M.W.Griffiths, and M.Corredig:The antiproliferative properties of the milk fat globule membrane are affected by extensive heating. Dairy Sci Technol 94, 439–453, 2014.
13. R.Jenness and J.Koops:Preparation and properties of a salt solution which simulates milk ultrafiltrate. Nederlands melk-en zuiveltijdschrift 16, 153–164, 1962.
14. R.Rombaut, J.V.Camp, and K.Dewettinck:Analysis of phospho- and sphingolipids in dairy products by a new HPLC method. J Dairy Sci 88, 482–488, 2005.
15. J.A.McBain, A.Eastman, C.S.Nobel, and G.C.Mueller:Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem Pharmacol 53, 1357–1368, 1997.
16. R.O'Connor, M.Heenan, and C.Duffy:Miniaturised in vitro assays in toxicity testing. In Animal cell culture techniques, ed. M.Clynes, Berlin, New York:Springer, 1998, 423–433.
17. P.Morin, R.Jimenez-Flores, and Y.Pouliot:Effect of processing on the composition and microstructure of buttermilk and its milk fat globule membranes. Int Dairy J 17, 1179–1187, 2007.
18. M.Bektas and S.Spiegel:Glycosphingolipids and cell death. Glycoconjugate J 20, 39–47, 2003.
19. H.Vesper, E.M.Schmelz, M.N.Nikolova-Karakashian, D.L.Dillehay, D.V.Lynch, et al.:Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr 129, 1239–1250, 1999.
20. Y.K.Wang, Y.L.Zhu, F.M.Qiu, T.Zhang, Z.G.Chen et al.:Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133+primary colon cancer cells. Carcinogenesis 31, 1376–1380, 2010.
21. P.L.Rice, M.Washington, S.Schleman, K.Scott Beard, L.J.Driggers et al.:Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and bad in human colon cancer cells. Can Res 63, 616–620, 2003.
22. M.Krausova and V.Korinek:Wnt signaling in adult intestinal stem cells and cancer. Cellular Signalling 26, 570–579, 2014.
23. P.Polakis:The oncogenic activation of beta-catenin. Curr Opin Gen Dev 9, 15–21, 1999.
24. A.Martensson, A.Oberg, A.Jung, K.Cederquist, R.Stenling et al.:Beta-catenin expression in relation to genetic instability and prognosis in colorectal cancer. Oncology Reports:17, 447–452, 2007.
25. E.M.Schmelz, P.C.Roberts, E.M.Kustin, L.A.Lemonnier, M.C.Sullards et al.:Modulation of intracellular β-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids. Can Res 61, 6723–6729, 2001.
26. K.W.Simon, P.C.Roberts, M.J.Vespremi, S.Manchen, and E.M.Schmelz:Regulation of beta-catenin and connexin-43 expression:Targets for sphingolipids in colon cancer prevention. Mol Nut Food Res 53, 332–340, 2009.